NCBiotech News

As I interviewed people who have completed the BioWork certification, and their instructors, I have learned a few things. If you have been thinking about making a career change, read on.

East Carolina University and the North Carolina Biotechnology Center are working together to bring new technologies to the marketplace.

Mayne Pharma has won an FDA OK for its topical corticosteroid LEXETTE to treat moderate to severe plaque psoriasis in patients 12 and older.

The Retinal Degeneration Fund is spinning out its own Raleigh-based biotech startup, Opus Genetics, aiming at curing blindness after landing $19 million in seed financing.

NCA&T eld a ribbon-cutting this week to officially open its new $6 million pavilion for ag research and education on its research farm in Greensboro.

After seven years as an early childhood educator, Fay-Ann Johnston found a refreshing new career opportunity through the BioWork course at Johnston Community College, leading to a good job at Novo Nordisk.

Director Dena Evans of the UNC Charlotte School of Nursing is working with partners to launch an innovative training program to prepare nurses to take healthcare to NC's rural communities.

NCA&T just got a $500,000 boost to its Aggie Commitment Trailblazer Scholars (ACTS) program, building on an initial gift of $1.5 million provided by the North Carolina GlaxoSmithKline Foundation.

NC State and UNC are among 10 mid-Atlantic universities participating in the NSF's I-Corps Hub program that will provide entrepreneurship training to academic researchers across all fields of science and engineering so they can bring new solutions to the marketplace.

NCA&T has landed a multi-million dollar award to establish “cutting-edge” research in biotechnology and materials science from the U.S. Department of Defense.

Merck is hosting a career fair this Saturday, September 18, from 10 a.m. until 1 p.m. on the grounds of St. Joseph AME Church, 2521 Fayetteville Street in Durham.

GreenLight Biosciences, with a growing R&D site in RTP, is the latest local company to go public using a SPAC, to accelerate its development of RNA products for human health and agriculture.

AgBiome, the fast-growing agricultural technology firm that harnesses plant microbiomes to develop novel crop protection products, has landed a whopping $116 million in funding.

Mackenzie Dixon didn't have much career direction when dropped out of high school and entered community college, but found a career opportunity as a contract process technician at Novo Nordisk in Clayton.

Thermo Fisher Scientific, a leader in North Carolina’s booming pharmaceutical contract manufacturing industry, is back in growth mode with plans to invest $154 million and create 290 more jobs at its sprawling Greenville campus.